Statistical Solutions

[...] We at Statistical Solutions are pleased to announce the launch of our new company website on February 3rd. The newly [...]

[...] , go to www.stat.harvard.edu/Faculty_Content/Rubin-short-bio.pdf From everyone at Statistical Solutions, we wish Professor Rubin a very happy birthday.     The post A Celebration of [...]

[...] Brian Sullivan, Statistician and Customer Support Manager with Statistical Solutions recently contributed to the PSI Missing Data Expert Group paper that was published in the [...]

[...] on 4th Workshop on Analysis of Incomplete Data (AID), Bamberg, Germany appeared first on Statistical Solutions. [...]

[...] What is Sample Size? A good statistical study is one that is well designed and leads to valid conclusions. This [...]

[...] of not committing a type II error. The two major factors affecting the power of a study are the sample size and the effect size. The larger the sample size is the smaller the effect size that can be [...]

[...] nQuery Advisor + nTerim 3.0 is the leading software for Sample Size & Power determination. nQuery Advisor + nTerim is trusted by the top 50 Pharma and [...]

[...] MANOVA ANCOVA Early stopping for futility in group sequential trials Plots Power Vs. Sample Size Plot Includes slide bar Spending Function Plot Two Options for Graphing Boundaries Assistants [...]

[...] The Prevention and Treatment of Missing Data in Clinical Trials Blog November 1st – 2nd 2011, Iselin, New Jersey by Andrew Grannell This was a short [...]

[...] We have created an nQuery Advisor user group for clinical trials on linkedIn. The group has been created for exiting and future users of nQuery Advisor [...]

[...] superiority, equivalence and non-inferiority are used frequently in publications on clinical trials. To someone starting out in clinical research these three terms and their precise [...]

[...] , more than 1000 humans have received Crucell’s adeno-platform based vaccine in clinical trials, while Bavarian Nordic’s MVA-BN platform has a safety record of use in more than 7300 [...]

[...] Great info-graphic from PPD on the process of discovering and bringing a new drug to the public which can typically cost a pharmaceutical or biotechnology company more than $1 [...]

[...] ; clinical trials most often involve comparing a new treatment with an existing treatment or a new drug against a placebo or existing drug. The goal of these trials is to show that the new drug or [...]

[...] Conference in Bristol on September 22-23. Andrew Grannell will present a paper on multiple imputation and it will also be the first outing for new customer support statistician Eoghan Murphy ( [...]

[...] setting in the chapel of Wills Hall, where I stood by the altar to preach the word of Multiple Imputation to those who had the stamina (or patience) to listen. I gave a brief introduction to [...]

[...] Multiple Imputation In Pharmaceutical Clinical Trials Using SOLAS for Missing Data Analysis Date: Tuesday 6th [...]

[...] and attempted to suggest some possible solutions to these issues using different forms of multiple imputation. The first morning session focused on the challenges in Educational and Health Research, [...]

[...] , tutorials and symposiums to choose from! Some of our favourites so far are: Mitigating Missing Data in Clinical Trials: Moving Toward Global Behavioral Change Impacts Efficacy, Safety, and [...]

[...] The Prevention and Treatment of Missing Data in Clinical Trials Blog November 1st – 2nd 2011, Iselin, New Jersey by Andrew Grannell [...]

[...] and Customer Support Manager with Statistical Solutions recently contributed to the PSI Missing Data Expert Group paper that was published in the Oct-Dec issue of the Wiley-Blackwell journal [...]

[...]  By ED SILVERMAN on the Wall Street Journal In response to ongoing debate over access to clinical trial data, the Institute of Medicine has released a widely anticipated report that recommends [...]

[...] Clinical trial data submitted for market authorization in the European Union must be made available for [...]

[...] Features and Tests Statistical Solutions is delighted to announce it’s latest release nQuery Advisor + nTerim 2.0. Click Here for Version Comparison Study Goal and Design Window: nQuery Advisor [...]

[...] .0 drew great interest from delegates, with many opting to sign up for our free 30 day trial. nQuery Advisor was a popular as ever and the new nTerim utility certainly added to the interest. Many [...]

[...] We have created an nQuery Advisor user group for clinical trials on linkedIn. The group has been created for exiting and future [...]

[...] nQuery Advisor + nTerim 3.0 is the leading software for Sample Size & Power determination. nQuery [...]

[...] Sensitivity analysis for a partially missing binary outcome in a two-arm randomized clinical trial. Article by  [...]

[...] patterns, inverse probability weighting (IPW), likelihood methods, multiple imputation and sensitivity analysis. Daniel Scharfstein gave a very interesting and comprehensive presentation on the [...]

[...] into how multiple imputation can improve and enhance your overall analysis Find out how sensitivity analysis can strengthen your understanding of your results The post Free Webinar…..Multiple [...]

[...] -University, Bamberg, gathered together many of the world’s leading experts in Missing Data Analysis, including Donald B. Rubin (Harvard University), Trivellore E. Raghunathan (University of [...]

[...] ended. Prof. Rubin then visited the Statistical Solutions booth for a demo of SOLAS for Missing Data Analysis and is pictured here with CEO, Mary Byrne. Wednesday August 24th was the special Water [...]

[...] Multiple Imputation In Pharmaceutical Clinical Trials Using SOLAS for Missing Data Analysis Date: Tuesday 6th December Time: 10AM – 11 AM GMT Duration: 60 minutes Speaker: [...]